Screen Reader Mode Icon
Dear Colleague,
 
Despite the international endorsement of multidisciplinarity as an essential part of breast cancer (BC) care, there is a wide gap between this universal recommendation and its effective implementation on the field. Multidisciplinary tumor board meetings (MTBs) are a way to offer patients access to multidisciplinary care, but its implementation is heterogeneous among different countries and also within countries.

In order to assess the functioning of MTBs for breast cancer patients in different countries around the world, we kindly request you to complete this short and simple survey.
 
This survey is being conducted by the Institut Jules Bordet and the OncoAlert Network, and led by Dr. Rita Conde (IPO Lisboa, Institut Jules Bordet), Dr. Sofia Ferreira (IPO Lisboa, Institut Jules Bordet), Dr. Mariana Brandão (Institut Jules Bordet), Dr. Gilberto Morgan (Director of the OncoAlert Network), and Prof. Evandro de Azambuja (Head of the Medical Support Team at Institut Jules Bordet, Brussels, Belgium).
 
This anonymous survey should take a maximum of 10 minutes to fill. 
For any questions regarding this survey please contact rita.conde@bordet.be.
Thank you very much for participating. 
0 of 29 answered
 

T